R&D spending share of top pharmaceutical companies 2018 and 2024

This statistic depicts the top 20 pharmaceutical companies based on R&D spending as revenue share in 2018, and a forecast for 2024. Roche spent 22 percent of their prescription drug revenue on research and development in 2018 and is expected to decrease the share to some 21 percent in 2024.

Top 10 pharmaceutical companies based on R&D spending as revenue share in 2018 and 2024*

20182024*
---
---
---
---
---
---
---
---
---
---
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2019

Region

Worldwide

Survey time period

as of May 2019

Supplementary notes

* R&D spending as a share of total prescription revenue. The statistic includes only the companies with the highest amount of R&D spending dollars.
** Forecast.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Novartis"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.